Development and Commercial Reporting. During the Term of this Agreement, Company will provide a half-yearly written progress report to Novavax summarizing the Development and Commercialization of Licensed Product(s) during the prior six months. Each such progress report will be provided to Novavax by Company no later than March 1st or September 1st (as the case may be) of each year following the Effective Date.
Appears in 5 contracts
Samples: H1n1 License Agreement (Novavax Inc), License Agreement (Novavax Inc), Option Agreement (Novavax Inc)
